zidovudine has been researched along with Anemia in 160 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (8.75) | 18.7374 |
1990's | 79 (49.38) | 18.2507 |
2000's | 34 (21.25) | 29.6817 |
2010's | 30 (18.75) | 24.3611 |
2020's | 3 (1.88) | 2.80 |
Authors | Studies |
---|---|
Abebe, M; Chanie, B; Getaneh, Z; Lemma, M; Temesgen, E; Wale, W; Walie, M | 1 |
Charoenphak, S; Nanthatanti, N; Sungkanuparph, S | 1 |
Yazie, TS | 1 |
Broadhurst, R; Flick, R; Hosseinpour, MC; Lim, R; Ngongondo, M; Ongubo, D; Rosenberg, NE; Speight, C; Stanley, CC; Tembo, P | 1 |
Alemu, J; Tamir, Z; Tsegaye, A | 1 |
Lynen, L; Phe, T; Sok, S; Thai, S; van Griensven, J; Veng, C | 1 |
Davies, MA; Dickinson, D; Egger, M; Ehmer, J; Garone, D; Gsponer, T; Hoffmann, C; Keiser, O; Maskew, M; Mulenga, L; Prozesky, H; Wandeler, G; Wood, R | 1 |
Bunupuradah, T; Chan, KC; Chokephaibulkit, K; Fong, SM; Han, N; Hansudewechakul, R; Huy, BV; Kariminia, A; Kumarasamy, N; Kurniati, N; Lumbiganon, P; Nallusamy, R; Ramautarsing, R; Razali, K; Saphonn, V; Sirisanthana, V; Sohn, AH; Yusoff, NK | 1 |
Gedefaw, L; Sahlemariam, Z; Yemane, T; Yilma, D | 1 |
Aka, E; Azondékon, A; Dicko, F; Eboua, TK; Ekouévi, D; Gueye, RD; Kouéta, F; Leroy, V; Malateste, K; Okomo, U; Renner, LA; Touré, P | 1 |
Aliyu, MH; Blevins, M; Megazzini, KM; Mohammed, MY; Parrish, DD; Shepherd, BE; Vermund, SH; Wester, CW | 1 |
Chersich, MF; Farley, TM; Luchters, S; Meda, N; Mwaura, M; Newell, ML; Sartorius, BK; Temmerman, M | 1 |
Lertcheewakarn, P; Tongprasert, F | 1 |
Oberdorfer, P; Pornprasert, S; Sirivatanapa, P; Wongnoi, R | 1 |
Bagratee, J; Grobler, A; Maharaj, NR; Moodley, D; Nandlal, V; Richardson, P | 1 |
Bekolo, CE; Bekoule, PS; Djidjou, H; Kollo, B; Sonkoue, C | 1 |
Blanche, S; Flynn, P; Giaquinto, C; Kakuda, TN; Komar, S; Lathouwers, E; Noguera-Julian, A; Opsomer, M; Van de Casteele, T; Welch, S | 1 |
Barr, E; Davies, J; Forster, JE; Kinzie, K; Levin, MJ; McFarland, EJ; Pappas, J; Paul, S; Smith, C; Weinberg, A | 1 |
Bonnet, F; Calmy, A; Ciaffi, L; Delhumeau, C; Fampou, JC; Hill, A; Menga, G; Nchotu Ngang, P; Rougemont, M; Stoll, B | 1 |
Gunda, DW; Kilonzo, SB; Mpondo, BC | 1 |
Arnould, L; Isaakidis, P; Khem, S; Khim, SA; Kuoch, S; Phe, T; Raguenaud, ME; Reid, T | 1 |
Bozzi, A; Brisdelli, F; D'Andrea, G | 1 |
Portilla, J | 1 |
Briand, N; Galactéros, F; Jourdain, G; Lallemant, M; Le Coeur, S; Ngo-Giang-Huong, N; Pissard, S; Pornprasert, S; Sanguansermsri, T; Tatu, T | 1 |
Ambrose, P; Devaleenol, B; Kumarasamy, N; Manohar, D; Mayer, KH; Poongulali, S; Saghayam, S; Solomon, S; Venkatesh, KK; Yepthomi, T | 1 |
Congote, LF; Difalco, MR; Dobocan, MC; Sadvakassova, G | 1 |
Dieng, AB; Diop, BM; Diop, SA; Diouf, A; Fall, MB; Lakh, A; Ndiaye, I; Niang, Kh; Seydi, M; Soumaré, M; Sow, A; Sow, PS; Tekpa, G | 1 |
Català, A; Fortuny, C; Jiménez, R; Lahoz, R; Noguera, A; Rovira, N; Sánchez, E | 1 |
Abaine, D; Aber, M; Ahimbisibwe, F; Akao, J; Akuma, S; Amuron, B; Amurwon, J; Angweng, E; Anywar, W; Atwiine, D; Atwiine, S; Awio, P; Babiker, A; Babiker, AG; Bafana, T; Bagaya, L; Bahendeka, S; Bakeinyaga, GT; Barungi, G; Bassett, M; Bohannon, J; Boocock, K; Borok, M; Bray, D; Breckenridge, A; Bulaya-Tembo, R; Buluma, E; Burke, A; Burke, C; Byakwaga, H; Byamukama, A; Byaruhanga, R; Chakonza, L; Chidziva, E; Chigwedere, E; Chimanzi, J; Chimbetete, C; Chirairo, H; Chirara, M; Chirema, O; Chitsungo, S; Chivhunga, T; Coutinho, A; Darbyshire, JH; Drasiku, A; Dunn, D; Enzama, R; Etukoit, B; Fadhiru, K; Ferrier, A; Florence, A; Foster, S; Gazzard, B; Generous, L; Gibb, DM; Gilks, C; Gilks, CF; Goodall, R; Grosskurth, H; Grundy, C; Haguma, W; Hakim, J; Hill, C; Hughes, P; Jamu, A; Jangano, M; Jones, S; Kabanda, J; Kabuye, G; Kagina, G; Kajungu, D; Kaleebu, P; Kambungu, A; Kankunda, R; Karungi, J; Kasirye, R; Katabira, E; Katabira, H; Katundu, P; Khauka, P; Kigozi, J; Kikaire, B; Kityo, C; Komugyena, J; Kulume, R; Kusiima, A; Kyomugisha, H; Labeja, O; Lara, AM; Latif, A; Levin, J; Lubwama, E; Lutwama, F; Lyagoba, F; Machingura, I; Machingura, J; Makota, S; Mambule, I; Mapinge, F; Mapuchere, C; Massa, R; Matenga, J; Matongo, M; Maweni, C; Mawora, A; McCormick, A; McLaren, A; Mdege, N; Moyo, K; Muchabaiwa, L; Mudzingwa, S; Mufuka-Kapuya, C; Muganzi, A; Mugisha, A; Mugurungi, O; Mugyenyi, P; Muhweezi, D; Muhwezi, A; Mukiibi, S; Mukose, A; Mulindwa, G; Mulindwa, M; Munderi, P; Murungi, S; Musana, H; Musoro, G; Mutowo, J; Mutsai, S; Muvirimi, C; Muyingo, S; Muzambi, M; Mwebesa, D; Mwesigwa, P; Nabankema, E; Nabongo, P; Naidoo, B; Nairuba, R; Nakahima, W; Nakazibwe, M; Nakiyingi, J; Nalumenya, R; Namale, L; Namara, W; Namata, I; Namazzi, A; Namuli, T; Namyalo, M; Nanfuka, A; Nanfuka, R; Nassuna, G; Ndembi, N; Newland, C; Ngorima, N; Nimwesiga, E; Nsibambi, D; Nyachwo, L; Nyiraguhirwa, D; Ochai, R; Ojiambo, H; Ojiambo, W; Oketta, F; Omony, W; Otim, T; Oyugi, J; Palfreeman, A; Pascoe, M; Pearce, G; Peto, L; Peto, T; Phiri, M; Pillay, D; Pozniak, A; Puddephatt, C; Rahim, S; Rauchenberger, M; Reid, A; Robertson, V; Ronald, A; Rooney, J; Ruberantwari, A; Rutikarayo, N; Sabiiti, J; Sadik, F; Sematala, F; Serwadda, D; Sheehan, S; Simango, M; Smith, M; Snowden, W; Spencer-Drake, C; Spyer, M; Ssali, F; Steens, JM; Svovanapasis, P; Takubwa, J; Taylor, K; Taziwa, F; Tinago, G; Todd, J; Tugume, S; Tukamushaba, J; Tumukunde, D; Tumusiime, C; Twijukye, C; Vere, L; Waita, R; Wakholi, BN; Walker, AS; Walusimbi, J; Wangati, K; Wanyama, J; Wapakhabulo, AC; Warambwa, C; Warara, R; Wavamunno, P; Weller, I; Whitworth, J; Wilkes, H; Winogron, D; Yirrell, D; Zalwango, A; Zalwango, E; Zawedde, C; Zengeza, E | 1 |
Briand, N; Hinjiranandana, T; Hotrawarikarn, S; Jourdain, G; Kanjanavanit, S; Lallemant, M; Le Coeur, S; McIntosh, K; Sirinontakan, S; Traisathit, P | 1 |
Sharma, SK | 1 |
Agarwal, D; Agrawal, NR; Chakravarty, J; Chaube, L; Rai, M; Sundar, S | 1 |
Castelnuovo, B; Kiragga, AN; Manabe, YC; Nakanjako, D | 1 |
Dryden-Peterson, S; Essex, M; Hughes, MD; Lockman, S; Makhema, J; Moffat, C; Moyo, S; Ogwu, A; Powis, K; Shapiro, RL | 1 |
Andersen, JW; Butt, AA; Chung, RT; Sherman, KE; Umbleja, T | 1 |
Antoni, AD; Baroncelli, S; Cavaliere, AF; Floridia, M; Genovese, O; Guaraldi, G; Molinari, A; Nardini, G; Pinnetti, C; Ricerca, BM; Tamburrini, E | 1 |
Amorelli-Chacel, ME; Brandão, RA; Brunetta, DM; Covas, DT; de Albernaz Muniz, RZ; de Lima, GM; De Santis, GC; Machado, AA; Vilar, FC | 1 |
Corbell, C; Fuller, S; Kalemeera, F; Katjitae, I; Lates, J; Mabirizi, D; Mengistu, A; Nwokike, J; Sagwa, E; Stergachis, A | 1 |
Mohiuddin, S; Rajesh, R; Varma, DM; Vidyasagar, S | 1 |
Bajunirwe, F; Kiwanuka, J; Nyesigire Ruhinda, E | 1 |
Koduri, PR; Parekh, S | 1 |
Bergallo, M; Bollero, C; Cavallo, R; Lembo, D; Leonardi, G; Merlino, C; Musso, T; Ponzi, AN; Re, D; Segoloni, GP | 1 |
Antoniou, T; Arbess, G; Gough, K; Yoong, D | 1 |
Amin, J; Hill, A; Law, M; Moyle, G; Sawyer, W | 1 |
Broadhead, R; Chen, S; Chitale, R; Hoover, D; Kafulafula, G; Katundu, P; Kumwenda, J; Kumwenda, N; Mukiibi, J; Nkhoma, C; Taha, TE | 1 |
Anglaret, X; Anzian, A; Bissagnene, E; Danel, C; Gabillard, D; Gomis, OB; Inwoley, A; Konga, C; Minga, A; Moh, R; Salamon, R; Sauvageot, D; Sorho, S | 1 |
Alvarez, D; Ball, L; Brau, N; Dieterich, DT; Moorehead, L; Sulkowski, MS | 1 |
Bowers, P; Henry, DH; Lamarca, A; Leitz, G; Slim, J | 1 |
Byakwaga, H; Darbyshire, JH; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Katabira, E; Kityo, C; Mugyenyi, P; Munderi, P; Reid, A; Ssali, F; Stöhr, W; Walker, AS | 1 |
Bührer, C; Casteleyn, S; Feiterna-Sperling, C; Loui, A; Obladen, M; Schmitz, T; Wahn, V; Weizsaecker, K | 1 |
Bharucha, KE; Bhosale, RA; Bollinger, RC; Bulakh, PM; Choi, TJ; Deshmukh, SD; Gupta, A; Gupte, N; Khandekar, MM; Kshirsagar, AS; Kulkarni, V; Nair, S; Nayak, U; Phadke, MA; Sastry, J; Sinha, G | 1 |
Bani-Sadr, F; Billaud, E; Cacoub, P; Carrat, F; Doll, J; Goderel, I; Penalba, C; Perronne, C; Pol, S; Welker, Y | 1 |
Calmy, A; Ditangco, R; Huffam, SE; Kaldor, JM; Saphonn, V; Srasuebkul, P; Zhou, J | 1 |
Altinbaş, A; Büyükaşik, Y; Ozkaya, G; Unal, S | 1 |
Bougnounou, R; Diallo, I; Drabo, J; Guiard-Schmid, JB; Nacoulma, EW; Ouédraogo, C; Some, Y; Tieno, H; Zoungrana, A | 1 |
Chaisson, RE; Charalambous, S; Churchyard, GJ; Fielding, KL; Grant, AD; Hoffmann, CJ; Innes, C; Sulkowski, MS; Thio, CL | 1 |
Aguirrebengoa, K; Asensi, V; Barreiro, P; Cervantes, M; Echeverria, S; Garcia-Samaniego, J; Núñez, M; Ocampo, A; Pascual, A; Soriano, V | 1 |
Arizcorreta-Yarza, A; Collado, A; Fernández-Fuertes, E; Girón-González, JA; González-Serrano, M; López-Cortés, LF; Lozano, F; Macías, J; Merino, D; Mira, JA; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Torres-Tortoso, M; Valera-Bestard, B | 1 |
Brooks, JT; Hanson, DL; Sullivan, PS | 1 |
Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N | 1 |
Bozzette, SA; Hay, J; Parker, R | 1 |
Karwacki, M; Kubiak, W; Ochocka, M | 1 |
Cao, G; Falguera, M; Perez-Mur, J; Puig, T | 1 |
Abraham, NG; Argani, I; Chertkov, JL; Jiang, S; Kappas, A; Levere, RD; Lutton, JD; Staudinger, R | 1 |
Chow, FP; Hamburger, AW; Zsebo, K | 1 |
Friedman, EA; Khurana, E; Lundin, AP; Rao, TK; Shrivastava, D; Sinert, R | 1 |
Lundberg, JH; Tefferi, A; Weitz, JJ; Witzig, TE | 1 |
Girolami, A; Mares, M; Sartori, MT; Stocco, D; Zerbinati, P | 1 |
Crofton, ME; Goldin, R; Wetton, CW | 1 |
Cooper, DA; Swanson, CE; Tindall, B | 1 |
Brown, RE; Henry, DH; McNeill, MV; Revicki, DA; Rios, A; Watson, T | 1 |
Abels, RI; McNeill, MV; Phair, JP; Sullivan, DJ | 1 |
Dourakis, S; Goldin, RD; Lindley, R; Parkin, J; Wilkins, M | 1 |
Abraham, NG; Chertkov, JL; Harrison, J; Jiang, S; Kappas, A; Levere, RD; Lutton, JD | 1 |
de Graeff-Meeder, ER; Prakken, AB; Scherpbier, HJ; van den Berg, H | 1 |
Bartz, CR; Benveniste, RE; Follis, KE; Grant, RF; Nolte, RE; Sager, PR; Tsai, CC | 1 |
Boucher, FD; Crain, MJ; Elkins, MM; McKinney, R; Mirochnick, M; Modlin, JF; Pelton, S; Ruff, A; Weller, S; Wilfert, C | 1 |
Lancaster, DJ; Palte, S; Ray, D | 1 |
Cavagnolo, G; Deambrogio, V; Fruttaldo, L; Gatti, G; Mongiò, F; Schettino, G | 1 |
Hamburger, AW | 1 |
Cross, A; Dellamonica, P; Dunkle, L; Gathe, J; Jemsek, JG; Mellors, JW; Murphy, R; Pavia, AT; Spruance, SL; Stool, E | 1 |
Moreno García, M | 1 |
Hester, EK; Peacock, JE | 1 |
Abkowitz, JL; Conrad, SH; Ha, JC; Mottet, NK; Nosbisch, C; Robinette, R; Ruppenthal, GC; Sackett, GP; Unadkat, JD | 1 |
Stevens, TP; Watson, WJ; Weinberg, GA | 1 |
Dao, B; Meda, N; Ouangré, A | 1 |
Chaisson, RE; Keruly, JC; Moore, RD | 1 |
Das, T; Ghosh, AK; Ray, PK; Subbulakshmi, V | 1 |
Allen, UD; Bowker, J; Forbes, JC; Gomez, MP; King, SM; Kirby, MA; Lapointe, N; Mukwaya, G; Raboud, J; Read, SE; Singer, J; Thorne, A; Tobin, J | 1 |
Conly, J; Fletcher, D; Keystone, D; Salit, I; Tseng, A; Walmsley, S | 1 |
Biesma, DH | 1 |
Albrecht, D; Lorenzen, T; Plettenberg, A; Stoehr, A; Weitzel, T | 1 |
Chow, KC; Lau, SM; Wang, JH; Yu, WL | 1 |
Fowler, MG | 1 |
Anastos, K; Augenbraun, M; Berhane, K; Cohen, M; Gange, SJ; Levine, AM; Masri-Lavine, L; Newman, M; Sanchez, M; Watts, H; Young, M | 1 |
Hinthorn, D; Luchi, M; Saberhagen, C; Warren, KA | 1 |
Gray, GE; Semba, RD | 1 |
Allen, UD; Goeree, R; Kirby, MA | 1 |
Farinas, CA | 1 |
Hanna, L | 1 |
Prescott, LM | 1 |
Dousman, L; Freund, YR; MacGregor, JT; Mohagheghpour, N; Riccio, ES; Sato, B | 1 |
Congote, LF; DiFalco, MR | 1 |
Lustermans, FA; Russel, MG; van Pelt, J; Wuite, J | 1 |
Booth, DK; Koch, MA; Lagakos, SW; Myers, MW; Pettinelli, C; Volberding, PA | 1 |
Chaisson, RE; Creagh, T; Keruly, J; Moore, RD; Richman, DD | 1 |
Miles, SA | 1 |
Angarano, G; Arici, C; Cristini, G; Guzzanti, E; Ippolito, G; Pagano, G; Puro, V; Serafin, I; Soscia, F; Suter, F | 1 |
Beall, GN; Benson, CA; Carey, J; Cone, LA; Eron, LJ; Fiala, M; Fischl, MA; Gabin, SJ; Gottlieb, MS; Henry, DH | 1 |
Böttiger, D; Li, SL; Oberg, B; Ståhle, L | 1 |
Abels, RI; Henry, DH; Jemsek, JG; Levin, AS; Levine, JD; Levine, RL; Nelson, RA; Rudnick, SA; Thompson, D | 1 |
Garcia-Tsao, G; Panzini, L; West, AB; Yoselevitz, M | 1 |
Gallicchio, VS; Hughes, NK | 1 |
Agarwal, R; Chidekel, J; Dearmas, L; Fischl, MA; Fletcher, MA; McCann, M; Myers, M; Patrone-Reese, J; Resnick, L; Uttamchandani, RB | 1 |
Bernstein-Singer, M; Gill, PS; Groshen, S; Levine, AM; Loureiro, C; Rarick, MU; Sullivan-Halley, J | 1 |
Brogan, KL; Zell, SC | 1 |
Hutlin, L; Lee, K; Miles, SA; Mitsuyasu, RT; Zsebo, KM | 1 |
Foa, P | 1 |
Chow, FP; Hamburger, AW | 1 |
Amigoni, S; Bozza, M; Caprioli, S; Carosi, G; Maggiolo, F; Suter, P | 1 |
Agrawal, KC; George, WJ; Gogu, SR; Hyslop, NE; Lertora, JJ | 1 |
Lohmeyer, J; Mueller-Eckhardt, C; Salama, A; Seeger, W | 1 |
Chaisson, RE; Creagh-Kirk, T; Easterbrook, PJ; Keruly, JC; Moore, RD; Richman, DD | 1 |
Holechek, MJ | 1 |
Cooper, DA; Swanson, CE | 1 |
Chow, FP; Hamburger, AW; Sutton, PA | 1 |
Aboulafia, DM; Mitsuyasu, RT | 1 |
Ballem, P; Calverley, D; Haley, L | 1 |
Holland, HK; Spivak, JL | 1 |
Bozzette, S; Connor, JD; Dieterich, D; Hochster, H; Liebes, L; Pettinelli, C; Reichman, RC; Sonke, RL; Spector, SA; Valentine, F | 1 |
DeVera, MC; Feinmehl, R; Haschek, WM; Scherba, G; Solter, P; Tompkins, MB; Tompkins, WA; Weigel, RM | 1 |
Sommadossi, JP; Weidner, DA | 1 |
Fischl, M; Galpin, JE; Groopman, JE; Henry, DH; Kennedy, P; Levine, JD; Miles, S; Robbins, W; Starrett, B; Zalusky, R | 1 |
Cardon, B; Gharakhanian, S; Navarette, MS; Rozenbaum, W | 1 |
Calabresi, P; Chu, SH; Darnowski, JW; Falcone, A; St Clair, MH; Wiemann, MC | 1 |
Brunetti, I; Calabresi, P; Chu, SH; Darnowski, JW; Falcone, A; Ruprecht, RM | 1 |
Barchi, E; Bertazzoni, U; Casoli, C; Magnani, G; Schianchi, C | 1 |
Buijs, L; Pietersz, RN; Reesink, HW; ten Veen, JH; van den Berg-Wolf, MG | 1 |
Feigal, D; Jacobson, MA; Peiperl, L; Porteous, D; Toy, PT; Volberding, PA | 1 |
Lusher, JM; Warrier, I | 1 |
Hendrix, J; Hilton, M; Marantz, PR; Samuels, JE; Sloan, V; Small, CB | 1 |
Balloul, E; Boudes, P; Sobel, A | 1 |
Nightingale, SC | 1 |
Durakis, S; Goldin, R; Lindley, R; Parkin, J | 1 |
Smiley, L | 1 |
Kaplan, LD; Volberding, PA | 1 |
Bryson, Y; Causey, DM; Fischl, MA; Grieco, MH; Groopman, JE; Laskin, OL; Mildvan, D; Richman, DD; Schooley, RT; Volberding, PA | 1 |
Barnes, DC; Fuchs, E; Quinn, TC; Spivak, JL | 1 |
Banks, S; Baseler, MW; Deyton, L; Falloon, J; Kirk, LE; Kovacs, JA; Lane, HC; Masur, H; Salzman, NP; Walker, RE | 1 |
Costello, C; Luckit, J; Mir, N | 1 |
Gil Aguado, A; Lavilla, P; Pintado, V; Valencia, ME | 1 |
Andrews, E; Barry, DW; Creagh-Kirk, T; Doi, P; Hoth, D; Nusinoff-Lehrman, S; Tilson, H | 1 |
Fischl, MA; Gottlieb, MS; Grieco, MH; Groopman, JE; Hirsch, MS; Laskin, OL; Leedom, JM; Mildvan, D; Richman, DD; Volberding, PA | 1 |
Carleton, S; Fauci, AS; Gralnick, HR; Kirk, LE; Kovacs, JA; Lane, HC; Masur, H; Parker, RI; Walker, RE | 1 |
13 review(s) available for zidovudine and Anemia
Article | Year |
---|---|
AZT: an old drug with new perspectives.
Topics: Administration, Cutaneous; Anemia; Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Erythroid Cells; Glycosylation; Humans; Immunotoxins; Iron; Prodrugs; Proteomics; Zidovudine | 2008 |
[Tenofovir as a strategy to avoid or limit adverse effects].
Topics: Adenine; Anemia; Anti-HIV Agents; Antimetabolites; Clinical Trials as Topic; DNA, Mitochondrial; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Glucose Metabolism Disorders; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Multicenter Studies as Topic; Organophosphonates; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zidovudine | 2008 |
B19 virus infection in renal transplant recipients.
Topics: Anemia; Antibodies, Monoclonal; Antibodies, Viral; Antilymphocyte Serum; Basiliximab; Cyclosporine; Cytomegalovirus Infections; Diagnosis, Differential; Disease Susceptibility; DNA, Viral; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin-1; Kidney Transplantation; Male; Mycophenolic Acid; Parvoviridae Infections; Parvovirus B19, Human; Phosphoproteins; Polymerase Chain Reaction; Postoperative Complications; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; T-Lymphocytes; Tacrolimus; Viral Load; Viral Matrix Proteins; Viremia; Zidovudine | 2003 |
Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies.
Topics: Anemia; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Hemoglobins; HIV Infections; Humans; Neutropenia; Randomized Controlled Trials as Topic; Stavudine; Viral Load; Zidovudine | 2004 |
[Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
Topics: Anemia; Anti-HIV Agents; Erythropoietin; HIV Infections; Humans; Recombinant Proteins; Time Factors; Zidovudine | 1997 |
Erythropoietin treatment for non-uremic patients: a personal view.
Topics: Anemia; Anti-HIV Agents; Arthritis, Rheumatoid; Blood Transfusion, Autologous; Chemotherapy, Adjuvant; Erythropoietin; Female; Humans; Male; Multiple Myeloma; Myelodysplastic Syndromes; Recombinant Proteins; Uremia; Zidovudine | 1999 |
Follow-up of children exposed to perinatal antiretrovirals.
Topics: Anemia; Anti-HIV Agents; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Pathogenesis of anemia during human immunodeficiency virus infection.
Topics: Adult; Anemia; Anemia, Iron-Deficiency; Anti-HIV Agents; Chronic Disease; Female; Folic Acid Deficiency; Global Health; HIV Infections; Humans; Male; Mycobacterium avium-intracellulare Infection; Parvoviridae Infections; Pregnancy; Vitamin A Deficiency; Vitamin B 12 Deficiency; Zidovudine | 2001 |
Hematopoietic growth factors as adjuncts to antiretroviral therapy.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; HIV Infections; Humans; Leukopenia; Zidovudine | 1992 |
Erythropoietin: clinical applications.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Erythropoietin; Humans; Kidney Diseases; Neoplasms; Recombinant Proteins; Zidovudine | 1991 |
Hematologic abnormalities in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Blood Coagulation Disorders; Hematologic Diseases; Humans; Leukopenia; Thrombocytopenia; Zidovudine | 1991 |
The haematological manifestations of acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Blood Coagulation Factors; Bone Marrow; Hematologic Diseases; Humans; Lupus Coagulation Inhibitor; Lymphopenia; Neutropenia; Thrombocytopenia; Zidovudine | 1990 |
Treatment of AIDS and its attendant malignancies.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease Susceptibility; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Sarcoma, Kaposi; Vinblastine; Vincristine; Zidovudine | 1989 |
38 trial(s) available for zidovudine and Anemia
Article | Year |
---|---|
Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.
Topics: Adult; Africa South of the Sahara; Anemia; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2013 |
Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: results from a phase 2 open-label trial (DIONE).
Topics: Adolescent; Anemia; CD4 Lymphocyte Count; Darunavir; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Nausea; Neutropenia; Reverse Transcriptase Inhibitors; Ritonavir; Sulfonamides; Time Factors; Viral Load; Vomiting; Zidovudine | 2014 |
Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; Treatment Outcome; Zidovudine | 2016 |
Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand.
Topics: Administration, Oral; alpha-Thalassemia; Anemia; Anti-HIV Agents; beta-Thalassemia; Blood Cell Count; DNA; Double-Blind Method; Drug Administration Schedule; Female; Hemoglobin E; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2009 |
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
Topics: Adenine; Adolescent; Adult; Africa; Aged; Anemia; Anti-Retroviral Agents; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Disease Progression; Drug Monitoring; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Neutrophils; Nevirapine; Organophosphonates; RNA, Viral; Tenofovir; Urea; Viral Load; Zidovudine | 2010 |
Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.
Topics: Adult; Anemia; Anti-HIV Agents; Female; Hemoglobins; HIV Infections; Humans; Male; Risk Factors; Uganda; Zidovudine | 2010 |
Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
Topics: Adult; Anemia; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome; Zidovudine | 2011 |
Anaemia in HIV-infected children: severity, types and effect on response to HAART.
Topics: Adolescent; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cross-Sectional Studies; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Logistic Models; Male; Nevirapine; Prevalence; Prospective Studies; Severity of Illness Index; Treatment Outcome; Uganda; Zidovudine | 2012 |
Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.
Topics: Agranulocytosis; Anemia; Anti-HIV Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hematocrit; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Nevirapine; Risk Factors; RNA, Viral; Zidovudine | 2004 |
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.
Topics: Adult; Anemia; Anti-HIV Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Blood Cell Count; Blood Platelets; Cohort Studies; Cote d'Ivoire; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Neutropenia; Prospective Studies; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2005 |
Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.
Topics: Adult; Anemia; Antiviral Agents; Body Weight; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Zidovudine | 2006 |
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
Topics: Adult; Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Incidence; Male; Predictive Value of Tests; Prevalence; Reverse Transcriptase Inhibitors; Severity of Illness Index; Uganda; Zidovudine; Zimbabwe | 2006 |
Clinically significant anemia in HIV-infected pregnant women in India is not a major barrier to zidovudine use for prevention of maternal-to-child transmission.
Topics: Adult; Anemia; Female; Folic Acid; HIV Infections; Humans; India; Infectious Disease Transmission, Vertical; Iron; Pregnancy; Zidovudine | 2007 |
Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
Topics: Adult; Anemia; Anti-HIV Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Zidovudine | 2007 |
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
Topics: Adult; Alkynes; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Developing Countries; Dizziness; Drug Tolerance; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nausea; Neutropenia; Prospective Studies; South Africa; Treatment Outcome; Viral Load; Vomiting; Zidovudine | 2008 |
Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
Topics: Adult; Anemia; Anti-HIV Agents; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Multivariate Analysis; Polyethylene Glycols; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome; Withholding Treatment; Zidovudine | 2008 |
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Patient Compliance; Peripheral Nervous System Diseases; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Study of the role of vitamin B12 and folinic acid supplementation in preventing hematologic toxicity of zidovudine.
Topics: Adult; Anemia; Bone Marrow Diseases; CD4 Lymphocyte Count; Female; Folic Acid; Hematologic Diseases; HIV Infections; Humans; Leucovorin; Male; Neutropenia; Prospective Studies; Vitamin B 12; Zidovudine | 1995 |
Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Anemia; Australia; Bisexuality; Homosexuality; Humans; Life Tables; Likelihood Functions; Male; Middle Aged; Muscular Diseases; Regression Analysis; Risk Factors; Safety; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome; Zidovudine | 1994 |
Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Follow-Up Studies; Health Status; Hematocrit; Humans; Injections, Subcutaneous; Male; Quality of Life; Recombinant Proteins; Regression Analysis; Treatment Outcome; Zidovudine | 1994 |
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anemia; Blood Transfusion; Combined Modality Therapy; Drugs, Investigational; Erythropoietin; Female; Hematocrit; Humans; Male; Middle Aged; Recombinant Proteins; Treatment Outcome; Zidovudine | 1993 |
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
Topics: Administration, Oral; Anemia; Drug Administration Schedule; Drug Tolerance; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1993 |
Recombinant human erythropoietin in the treatment of anemia in AIDS patients receiving concomitant amphotericin B and zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anemia; Erythropoietin; Histoplasmosis; Humans; Recombinant Proteins; Zidovudine | 1993 |
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Infections; Humans; Male; Nausea; Neutropenia; Stavudine; Vomiting; Zidovudine | 1997 |
Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
Topics: Anemia; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Administration Schedule; Female; HIV Seropositivity; Humans; Male; Neutropenia; Risk Factors; Thrombocytopenia; Zidovudine | 1992 |
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Blood Transfusion; Dose-Response Relationship, Drug; Double-Blind Method; Erythropoietin; Female; Hematocrit; Humans; Male; Middle Aged; Quality of Life; Recombinant Proteins; Statistics as Topic; Zidovudine | 1992 |
Recombinant human erythropoietin and the treatment of anemia in patients with AIDS or advanced ARC not receiving ZDV.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Double-Blind Method; Erythropoietin; Humans; Multicenter Studies as Topic; Recombinant Proteins; Zidovudine | 1992 |
A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Bisexuality; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Drug Evaluation; Follow-Up Studies; HIV Antigens; HIV-1; Homosexuality; Humans; Injections, Intramuscular; Interferon alpha-2; Interferon Type I; Interferon-alpha; Leukocyte Count; Liver; Male; Neutropenia; Opportunistic Infections; Recombinant Proteins; Sarcoma, Kaposi; Zidovudine | 1991 |
Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Anemia; Chemical and Drug Induced Liver Injury; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Humans; Leukopenia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Prospective Studies; Time Factors; Vomiting; Zidovudine | 1990 |
Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Blood Transfusion; Bone Marrow; Double-Blind Method; Erythropoietin; Female; Hematocrit; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Recombinant Proteins; Zidovudine | 1990 |
Vitamin B12 injections in patients treated with zidovudine.
Topics: Anemia; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Vitamin B 12; Zidovudine | 1990 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Anemia; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Erythropoietin; Ganciclovir; Humans; Zidovudine | 1989 |
Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
Topics: Acquired Immunodeficiency Syndrome; Agranulocytosis; AIDS-Related Complex; Anemia; Clinical Trials as Topic; Humans; Pneumonia, Pneumocystis; Time Factors; Zidovudine | 1989 |
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Double-Blind Method; Humans; Opportunistic Infections; Randomized Controlled Trials as Topic; Survival Rate; Thrombocytopenia; Zidovudine | 1989 |
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Double-Blind Method; Drug Evaluation; Granulocytes; HIV; Humans; Leukocyte Count; Male; Middle Aged; Prospective Studies; Random Allocation; Sarcoma, Kaposi; Zidovudine | 1989 |
Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS).
Topics: Adult; Anemia; Double-Blind Method; Female; HIV Seropositivity; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Thrombocytopenia; Zidovudine | 1988 |
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; AIDS-Related Complex; Anemia; Antiviral Agents; Blood Transfusion; Bone Marrow; Clinical Trials as Topic; Double-Blind Method; Erythrocyte Count; Female; Hemoglobins; Humans; Leukocyte Count; Male; Neutropenia; Platelet Count; Random Allocation; Thymidine; Vitamin B 12; Zidovudine | 1987 |
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Antiviral Agents; Drug Evaluation; Erythrocyte Indices; Erythropoiesis; Hemoglobins; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Sarcoma, Kaposi; Thymidine; Zidovudine | 1988 |
109 other study(ies) available for zidovudine and Anemia
Article | Year |
---|---|
Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study.
Topics: Adult; Anemia; Antiretroviral Therapy, Highly Active; Ethiopia; Female; HIV Infections; Hospitals, Special; Humans; Middle Aged; Referral and Consultation; Retrospective Studies; Zidovudine | 2021 |
Progression of non-anemic macrocytosis to anemia in HIV-positive persons receiving zidovudine-containing regimens in a resource-limited setting.
Topics: Adult; Anemia; Anti-HIV Agents; Female; HIV Infections; HIV Seropositivity; Humans; Male; Retrospective Studies; Zidovudine | 2022 |
Derangement of Liver Enzymes, Hyperglycemia, Anemia, and Associated Factors among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Regimen in Ethiopia: A Prospective Cohort Study.
Topics: Adult; Anemia; Anti-HIV Agents; Blood Glucose; Ethiopia; Female; HIV Infections; Humans; Hyperglycemia; Liver; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Regression Analysis; Surveys and Questionnaires; Tenofovir; Zidovudine | 2021 |
Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV Infections; Humans; Malawi; Male; Middle Aged; Odds Ratio; Prevalence; Reverse Transcriptase Inhibitors; Risk Factors; Zidovudine | 2018 |
Anemia among HIV Infected Individuals Taking ART with and without Zidovudine at Addis Ababa, Ethiopia.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Ethiopia; Female; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Young Adult; Zidovudine | 2018 |
Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment.
Topics: Adult; Anemia; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Retrospective Studies; Risk Factors; Stavudine; Zidovudine | 2013 |
Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.
Topics: Adult; Africa, Southern; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Female; HIV Infections; Humans; International Cooperation; Male; Middle Aged; Treatment Outcome; Zidovudine | 2013 |
Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.
Topics: Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asia, Southeastern; Child; Child, Preschool; Female; HIV Infections; Humans; Incidence; India; Kaplan-Meier Estimate; Male; Risk Factors; Treatment Outcome; Zidovudine | 2013 |
Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
Topics: Adolescent; Adult; Anemia; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nevirapine; Risk Factors; Social Class; Surveys and Questionnaires; Zidovudine | 2013 |
Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
Topics: Africa, Western; Anemia; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Female; HIV Infections; Humans; Male; Retrospective Studies; Zidovudine | 2013 |
Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria.
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Linear Models; Male; Middle Aged; Nigeria; Retrospective Studies; Reverse Transcriptase Inhibitors; Rural Population; Socioeconomic Factors; Time Factors; Treatment Outcome; Zidovudine | 2014 |
A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART).
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Retrospective Studies; Thailand; Young Adult; Zidovudine | 2014 |
Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of HIV decreases cord and after delivery red blood production without altering the development of hemoglobin.
Topics: Adolescent; Adult; Anemia; Anti-Retroviral Agents; Chemoprevention; Cross-Sectional Studies; Erythrocyte Count; Erythropoiesis; Female; Hemoglobins; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Young Adult; Zidovudine | 2014 |
Anaemia in pregnancy is associated with advanced HIV disease.
Topics: Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; Humans; Incidence; Multivariate Analysis; Pregnancy; Pregnancy Complications, Hematologic; Prevalence; Retrospective Studies; Risk Factors; South Africa; Urinary Tract Infections; Zidovudine | 2014 |
Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; Chemical and Drug Induced Liver Injury; Early Diagnosis; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Stavudine; Zidovudine | 2014 |
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
Topics: Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thrombocytopenia; Zidovudine | 2015 |
Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study.
Topics: Adult; Aged; Ambulatory Care Facilities; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Cross-Sectional Studies; Female; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index; Tanzania; Young Adult; Zidovudine | 2016 |
Evaluation of a systematic substitution of zidovudine for stavudine-based HAART in a program setting in rural Cambodia.
Topics: Anemia; Antiretroviral Therapy, Highly Active; Body Mass Index; Cambodia; CD4 Lymphocyte Count; HIV Infections; Humans; Patient Compliance; Retrospective Studies; Risk Factors; Rural Population; Stavudine; Zidovudine | 2008 |
Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting.
Topics: Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; India; Poverty; Stavudine; Treatment Outcome; Zidovudine | 2009 |
Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity.
Topics: Active Transport, Cell Nucleus; Anemia; Animals; Binding Sites; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Fibroblasts; Glycophorins; Humans; Kidney; Leukemia, Erythroblastic, Acute; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Polypyrimidine Tract-Binding Protein; Protein Structure, Tertiary; Recombinant Proteins; RNA Interference; RNA-Binding Proteins; Skin; Thrombospondins; Time Factors; Transduction, Genetic; Zidovudine | 2009 |
[Tolerance study of a triple first-line antiretroviral combination zidovudine, lamivudine and efavirenz in Dakar, Senegal].
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anemia; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Drug Tolerance; HIV-1; Humans; Lamivudine; Senegal; Zidovudine | 2009 |
Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen.
Topics: Adult; Anemia; Anti-HIV Agents; Chemoprevention; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2010 |
Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand.
Topics: Anemia; Confidence Intervals; Drug Monitoring; Female; Hematologic Tests; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Linear Models; Neutropenia; Neutrophils; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Thailand; Zidovudine | 2010 |
Zidovudine-induced anaemia in HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Antiretroviral Therapy, Highly Active; Hemoglobins; Humans; India; Myeloid Progenitor Cells; Sex Factors; Zidovudine | 2010 |
High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Hemoglobins; Humans; India; Male; Myeloid Progenitor Cells; Prevalence; Retrospective Studies; Reverse Transcriptase Inhibitors; Sex Factors; Zidovudine | 2010 |
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin.
Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Polyethylene Glycols; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Time Factors; Treatment Outcome; Zidovudine | 2011 |
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens.
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2011 |
Hematological abnormalities in HIV-infected patients.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; Blood Cell Count; Brazil; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; Hematologic Diseases; Hemoglobins; HIV Infections; HIV-1; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; RNA, Viral; Thrombocytopenia; Viral Load; Young Adult; Zidovudine | 2011 |
Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa.
Topics: Adult; Aged; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Databases, Factual; Electronic Health Records; Female; HIV Infections; Humans; Male; Medical Record Linkage; Middle Aged; Namibia; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Young Adult; Zidovudine | 2012 |
Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
Topics: Adult; Anemia; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Female; Hemoglobins; HIV Infections; Humans; Incidence; India; Male; Multivariate Analysis; Prospective Studies; Risk Factors; Severity of Illness Index; Stavudine; Zidovudine | 2011 |
Zidovudine-related anemia with reticulocytosis.
Topics: Adult; Anemia; Erythrocyte Indices; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Reticulocyte Count; Time Factors; Zidovudine | 2003 |
Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid.
Topics: Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Interactions; Epilepsy, Complex Partial; HIV Infections; Humans; Lamivudine; Male; Valproic Acid; Zidovudine | 2004 |
Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Black People; Cell Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Female; Hemoglobins; Hepatitis C, Chronic; Hispanic or Latino; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Protease Inhibitors; Recombinant Proteins; Reticulocytes; Retrospective Studies; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors; Treatment Outcome; White People; Zidovudine | 2007 |
Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
Topics: Anemia; Antiretroviral Therapy, Highly Active; Confidence Intervals; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Neutropenia; Odds Ratio; Perinatal Care; Pregnancy; Prospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Zidovudine | 2007 |
FDA notifications. FDA issues public health advisory about ESAs.
Topics: Anemia; Darbepoetin alfa; Dose-Response Relationship, Drug; Epoetin Alfa; Erythropoietin; Humans; Recombinant Proteins; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 2007 |
Prior antiretroviral therapy experience protects against zidovudine-related anaemia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asia; Developing Countries; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Zidovudine | 2007 |
[Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].
Topics: Adult; alpha-Thalassemia; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Diagnosis, Differential; Folic Acid; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Zidovudine | 2007 |
[Haematological parameters evolution during the antiretroviral therapy of HIV infected patients in Burkina-Faso].
Topics: Adolescent; Adult; Anemia; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Burkina Faso; Female; Follow-Up Studies; Hematologic Diseases; Hemoglobins; HIV Infections; Humans; Lymphopenia; Male; Middle Aged; Neutropenia; Retrospective Studies; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2007 |
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.
Topics: Adult; Anemia; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Spain; Thrombocytopenia; Zidovudine | 2007 |
Impact on hemoglobin of starting combination antiretroviral therapy with or without zidovudine in anemic HIV-infected patients.
Topics: Adolescent; Adult; Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Proportional Hazards Models; Zidovudine | 2008 |
A cost analysis of approved antiretroviral strategies in persons with advanced human immunodeficiency virus disease and zidovudine intolerance.
Topics: Acquired Immunodeficiency Syndrome; Agranulocytosis; Algorithms; Anemia; Costs and Cost Analysis; Decision Support Techniques; Didanosine; Erythrocyte Transfusion; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; HIV Infections; Humans; Pancreatitis; Quality of Life; Zidovudine | 1994 |
[Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients].
Topics: Acquired Immunodeficiency Syndrome; Anemia; Chronic Disease; Erythropoietin; Humans; Zidovudine | 1994 |
Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Topics: Anemia; Animals; Bone Marrow; Bone Marrow Cells; Cell Death; Cells, Cultured; Drug Interactions; Female; Hematopoiesis; Hematopoietic Stem Cells; Heme; HIV Reverse Transcriptase; HIV-1; Interleukin-1; Leukopenia; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Reverse Transcriptase Inhibitors; Spleen; Time Factors; Zidovudine | 1993 |
Failure of stem cell factor to ameliorate AZT-induced anemia in immunodeficient mice.
Topics: Anemia; Animals; Bone Marrow; Colony-Forming Units Assay; Erythropoietin; Female; Hematocrit; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cells; Leukemia Virus, Murine; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Spleen; Stem Cell Factor; Zidovudine | 1993 |
The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
Topics: Adult; AIDS-Associated Nephropathy; Anemia; Case-Control Studies; Diabetic Nephropathies; Erythropoietin; Female; Ferrous Compounds; Hematocrit; Humans; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Zidovudine | 1995 |
Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
Topics: 2-Chloroadenosine; Anemia; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Deoxyadenosines; Fatal Outcome; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Male; Methotrexate; Middle Aged; Neoplastic Stem Cells; Prednisone; Salvage Therapy; Vidarabine; Vincristine; Zidovudine | 1994 |
Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Topics: Adolescent; Adult; Anemia; Blood Coagulation Disorders; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hemophilia A; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Pancytopenia; Thrombocytopenia; Treatment Outcome; Zidovudine | 1994 |
Periportal fibrosis secondary to transfusion siderosis in two patients with acquired immune deficiency syndrome (AIDS) treated with zidovudine--a confusing ultrasound appearance.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Fibrosis; Humans; Liver Diseases; Male; Portal System; Siderosis; Transfusion Reaction; Ultrasonography; Zidovudine | 1993 |
Iron overload in multiply transfused patients who are HIV seropositive.
Topics: Adult; Aged; Anemia; HIV Seropositivity; Humans; Iron; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Transfusion Reaction; Zidovudine | 1993 |
Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
Topics: Anemia; Animals; Body Weight; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Drug Synergism; Erythropoietin; Female; Hematopoiesis; Hematopoietic Stem Cells; Heme; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutropenia; Thrombocytopenia; Weight Loss; Zidovudine | 1993 |
[The treatment of 12 HIV-infected children with zidovudine].
Topics: Adolescent; AIDS-Related Opportunistic Infections; Anemia; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Infant; Leukopenia; Male; Zidovudine | 1993 |
Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus.
Topics: Anemia; Animals; Antibodies, Viral; Base Sequence; DNA Primers; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Leukocytes, Mononuclear; Lymph Nodes; Lymphocyte Subsets; Macaca fascicularis; Male; Molecular Sequence Data; Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Viremia; Zidovudine | 1993 |
[The use of erythropoietin in HIV myelodysplasias. Preliminary study].
Topics: Adult; Anemia; Erythropoietin; HIV Infections; Humans; Recombinant Proteins; Zidovudine | 1993 |
Effects of combinations of stem cell factor and hemin on erythropoiesis after azidothymidine treatment of immunosuppressed mice.
Topics: Anemia; Animals; Bone Marrow; Drug Evaluation, Preclinical; Drug Interactions; Erythropoiesis; Hematocrit; Hemin; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Stem Cell Factor; Zidovudine | 1996 |
Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
Topics: Adult; Anemia; Anti-HIV Agents; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Zidovudine | 1998 |
Fetal, infant, and maternal toxicity of zidovudine (azidothymidine) administered throughout pregnancy in Macaca nemestrina.
Topics: Anemia; Animals; Animals, Newborn; Anti-HIV Agents; Area Under Curve; Bone Marrow; Erythrocyte Indices; Erythropoietin; Female; Fetal Death; Fetal Resorption; Fetus; Hematocrit; Hemoglobins; Leukocyte Count; Macaca nemestrina; Organ Size; Placenta; Platelet Count; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Random Allocation; Zidovudine | 1998 |
Profound anemia in a newborn infant of a mother receiving antiretroviral therapy.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Leukocyte Count; Male; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zalcitabine; Zidovudine | 1998 |
HIV, maternal anemia and perinatal intervention using zidovudine. DITRAME Study Group (ANRS 049 Clinical Trial).
Topics: Adult; Anemia; Anti-HIV Agents; Burkina Faso; Cross-Sectional Studies; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prevalence; Zidovudine | 1998 |
Anemia and survival in HIV infection.
Topics: Adult; Anemia; Anti-HIV Agents; Anti-Infective Agents; Blood Transfusion; Erythropoietin; Female; Ganciclovir; Hemoglobins; HIV Infections; Humans; Incidence; Longitudinal Studies; Male; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1998 |
Mechanism of protein A-induced amelioration of toxicity of anti-AIDS drug, zidovudine.
Topics: Anemia; Animals; Anti-HIV Agents; Leukopenia; Male; Mice; Reverse Transcriptase Inhibitors; Staphylococcal Protein A; Zidovudine | 1998 |
Serum immunoreactive erythropoietin levels and associated factors amongst HIV-infected children.
Topics: Anemia; Anti-HIV Agents; Bahamas; Canada; Child; Child, Preschool; Cross-Sectional Studies; Erythropoietin; Female; Hemoglobins; HIV Infections; Humans; Infant; Male; Renal Insufficiency; Zidovudine | 1998 |
Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.
Topics: Adult; Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Severe anemia as a newly recognized side-effect caused by lamivudine.
Topics: Anemia; Anti-HIV Agents; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Parvovirus B19 infection in a human immunodeficiency virus-infected patient with anemia.
Topics: Adult; Anemia; Anti-HIV Agents; Erythema Infectiosum; HIV Infections; Humans; Male; Zidovudine | 2000 |
Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; Hemoglobins; HIV Infections; HIV Seropositivity; HIV-1; Humans; Middle Aged; Multivariate Analysis; Odds Ratio; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2001 |
Transient visual loss due to severe anemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Anti-HIV Agents; Cytomegalovirus Retinitis; Diagnosis, Differential; Humans; Ischemia; Male; Retinal Vessels; Vision, Low; Zidovudine | 1999 |
Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.
Topics: Anemia; Anti-HIV Agents; Blood Transfusion; Child; Cost-Benefit Analysis; Decision Trees; Erythropoietin; Health Care Costs; HIV Infections; Humans; Outcome Assessment, Health Care; Sensitivity and Specificity; Zidovudine | 1997 |
Anemia in HIV disease.
Topics: Anemia; Anti-HIV Agents; Bone Marrow; Erythropoiesis; Erythropoietin; HIV Infections; Humans; Kidney; Recombinant Proteins; Zidovudine | 1998 |
Epoietin alfa (EPO) for anemia.
Topics: Anemia; Anti-HIV Agents; Clinical Trials as Topic; Erythropoietin; Female; HIV Infections; Humans; Male; Pregnancy; Recombinant Proteins; Zidovudine | 1998 |
Medical highlights of the 12th World AIDS Conference.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; AIDS Vaccines; Anemia; Anti-HIV Agents; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Recombinant Proteins; Research; Switzerland; Zidovudine | 1998 |
Immunohematotoxicity studies with combinations of dapsone and zidovudine.
Topics: AIDS-Related Opportunistic Infections; Anemia; Animals; Anti-HIV Agents; Antiprotozoal Agents; Bone Marrow; Concanavalin A; Dapsone; Dose-Response Relationship, Drug; Drug Interactions; Female; Leukopenia; Lymph Nodes; Lymphocyte Activation; Methemoglobinemia; Mice; Mice, Inbred BALB C; Neutropenia; Pneumonia, Pneumocystis; Thrombocytosis; Thymus Gland; Zidovudine | 2001 |
Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells.
Topics: Anemia; Animals; Antimetabolites; Bone Marrow Cells; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium; Erythropoietin; HL-60 Cells; Humans; Insulin-Like Growth Factor II; Interleukin-3; Jurkat Cells; Liver; Mice; Recombinant Fusion Proteins; Thymidine; Zidovudine | 2002 |
Porphyria cutanea tarda in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Fluconazole; Humans; Male; Middle Aged; Porphyria Cutanea Tarda; Porphyrins; Zidovudine | 1992 |
Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Topics: Acquired Immunodeficiency Syndrome; Actuarial Analysis; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Anemia; Blood Transfusion; Case-Control Studies; CD4-Positive T-Lymphocytes; Female; Follow-Up Studies; Hematocrit; Humans; Incidence; Leukocyte Count; Male; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Racial Groups; Risk Factors; Severity of Illness Index; Survival Analysis; Zidovudine | 1992 |
Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. The Italian Study Group on Occupational Risk of HIV Infection.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia; Female; Follow-Up Studies; Health Personnel; Hematologic Tests; HIV Infections; Humans; Italy; Male; Middle Aged; Neutropenia; Occupational Diseases; Prospective Studies; Retrospective Studies; Zidovudine | 1992 |
Long-term tolerance and efficacy of 3'-azidothymidine and 3'-fluorothymidine treatment of asymptomatic monkeys infected with simian immunodeficiency virus.
Topics: Anemia; Animals; Antiviral Agents; Blood Cell Count; CD4 Antigens; Dideoxynucleosides; Enzymes; Leukopenia; Macaca fascicularis; Simian Acquired Immunodeficiency Syndrome; Zidovudine | 1992 |
Bacillary peliosis hepatis as a cause of acute anemia in a patient with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkaline Phosphatase; Ampicillin; Anemia; Bilirubin; Biopsy; Blood Component Transfusion; Blood Transfusion; Hematocrit; Humans; Liver; Male; Microscopy, Electron; Peliosis Hepatis; Platelet Count; Sulbactam; Thrombocytopenia; Tomography, X-Ray Computed; Zidovudine | 1992 |
Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
Topics: Anemia; Animals; Bone Marrow Cells; Dose-Response Relationship, Drug; Erythropoietin; Female; GPI-Linked Proteins; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Membrane Glycoproteins; Mesothelin; Mice; Mice, Inbred C57BL; Proteins; Zidovudine | 1992 |
Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Anemia; CD4-Positive T-Lymphocytes; Erythropoietin; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Zidovudine | 1991 |
Hematologic toxicity of zidovudine in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Colony-Stimulating Factors; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Leukopenia; Recombinant Proteins; Zidovudine | 1990 |
Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Colony-Forming Units Assay; Erythroid Precursor Cells; Erythropoietin; Granulocytes; Hematopoietic Cell Growth Factors; HIV; HIV Infections; Humans; Lymphocytes; Macrophages; Monocytes; Neutropenia; Recombinant Proteins; Stem Cell Factor; Thrombocytopenia; Virus Replication; Zidovudine | 1991 |
Epoetin alpha approved for anemic AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Erythropoietin; Humans; United States; United States Food and Drug Administration; Zidovudine | 1991 |
In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Bone Marrow; Disease Models, Animal; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Female; Hematocrit; Mice; Mice, Inbred C57BL; Pregnancy; Reticulocytes; Time Factors; Zidovudine | 1991 |
A simple scoring system to assess risk of hematological side effects in zidovudine recipients.
Topics: Anemia; Female; HIV Infections; Humans; Male; Methods; Neutropenia; Risk Factors; Zidovudine | 1991 |
Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E.
Topics: Anemia; Animals; Bone Marrow; Colony-Forming Units Assay; Erythroid Precursor Cells; Erythropoietin; Interleukin-3; Male; Mice; Recombinant Proteins; Tocopherols; Vitamin E; Zidovudine | 1991 |
High-dose IgG for neutropenic patients with acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Anemia; Hematopoiesis; Humans; Immunoglobulin G; Neutropenia; Thrombocytopenia; Zidovudine | 1991 |
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Black People; Female; Follow-Up Studies; Hispanic or Latino; HIV Infections; Humans; Male; Multivariate Analysis; Opportunistic Infections; Prospective Studies; Risk Factors; Treatment Outcome; Zidovudine | 1991 |
Epoetin alfa for predialysis and AZT-treated HIV-positive patients.
Topics: Anemia; Erythropoietin; HIV Seropositivity; Humans; Kidney Failure, Chronic; Zidovudine | 1991 |
FDA approves Epoetin Alfa use for AZT patients.
Topics: Anemia; Erythropoietin; HIV Infections; HIV-1; Humans; United States; United States Food and Drug Administration; Zidovudine | 1991 |
Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study Group.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Australia; Body Weight; CD4-Positive T-Lymphocytes; Centers for Disease Control and Prevention, U.S.; Dose-Response Relationship, Drug; Drug Evaluation; Hemoglobins; Humans; Leukocyte Count; Models, Biological; Multicenter Studies as Topic; United States; Zidovudine | 1990 |
Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
Topics: Anemia; Animals; Bone Marrow; Dose-Response Relationship, Drug; Erythropoietin; Female; Hematopoietic Stem Cells; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Spleen; Zidovudine | 1991 |
Red blood cell alloimmunization in transfused patients on AZT.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Autoantibodies; Erythrocytes; Humans; Isoantibodies; Male; Retrospective Studies; Transfusion Reaction; Zidovudine | 1991 |
FDA approves AZT for pediatric AIDS patients under 13.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Child; Child, Preschool; Humans; Infant; Zidovudine | 1990 |
Zidovudine toxicity to cats infected with feline leukemia virus.
Topics: Anemia; Animals; Antibodies; Antigens, Viral; Bone Marrow; Cats; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythrocyte Count; Fluorescent Antibody Technique; Hematocrit; Hemoglobins; Leukemia Virus, Feline; Leukemia, Experimental; Regression Analysis; Time Factors; Zidovudine | 1990 |
3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
Topics: Anemia; Butyrates; Butyric Acid; Dose-Response Relationship, Drug; Globins; Hemoglobins; Humans; Leukemia, Erythroblastic, Acute; Protein Biosynthesis; Transcription, Genetic; Tumor Cells, Cultured; Zalcitabine; Zidovudine | 1990 |
Erythropoietin for zidovudine-induced anemia.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Erythropoietin; Humans; Recombinant Proteins; Zidovudine | 1990 |
Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity.
Topics: Anemia; Animals; Cell Line; Cytopathogenic Effect, Viral; Female; HIV; Leukopenia; Mice; Mice, Inbred BALB C; Uracil; Uridine; Zidovudine | 1990 |
Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Dose-Response Relationship, Drug; Female; Kinetics; Leukemia, Experimental; Leukopenia; Mice; Mice, Inbred BALB C; Rauscher Virus; Uracil; Uridine; Zidovudine | 1990 |
Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adenosine Deaminase; Adult; AIDS-Related Complex; Anemia; Erythrocytes; HIV-1; Humans; Zidovudine | 1990 |
[Treatment of AIDS patients with zidovudine].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Pancytopenia; Probability; Prognosis; Prospective Studies; Zidovudine | 1990 |
Red cell transfusion therapy for anemia in patients with AIDS and ARC: incidence, associated factors, and outcome.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Anti-Bacterial Agents; Blood Transfusion; Bone Marrow; Erythrocyte Transfusion; Humans; Mycobacterium avium-intracellulare Infection; Zidovudine | 1990 |
Retrovir therapy in hemophilic children with symptomatic human immunodeficiency virus infection: efficacy and toxicity.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; AIDS-Related Complex; Anemia; Child; Drug Evaluation; Hemophilia A; Humans; Neutropenia; Opportunistic Infections; Zidovudine | 1990 |
Zidovudine therapy in an inner city population.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Female; Humans; Leukopenia; Male; Nausea; New York City; Patient Compliance; Social Class; Substance Abuse, Intravenous; Zidovudine | 1990 |
[Tolerance of zidovudine in patients with beta-thalassemia].
Topics: Acquired Immunodeficiency Syndrome; Anemia; Female; Humans; Middle Aged; Thalassemia; Zidovudine | 1989 |
Iron deposition in liver in zidovudine-related transfusion-dependent anaemia.
Topics: Anemia; Humans; Iron; Liver; Transfusion Reaction; Zidovudine | 1989 |
Serum immunoreactive erythropoietin in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Complex; Anemia; Blood Cell Count; Erythropoietin; Female; Hemoglobins; HIV Seropositivity; Humans; Longitudinal Studies; Male; Radioimmunoassay; Zidovudine | 1989 |
The blood transfusion service and zidovudine treatment for AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Antiviral Agents; Blood Transfusion; Humans; Thymidine; Zidovudine | 1987 |
[Severe anemia after administration of zidovudine].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Humans; Male; Thymidine; Zidovudine | 1988 |
Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anemia; Blood Transfusion; Female; Follow-Up Studies; Hemoglobins; Homosexuality; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia, Pneumocystis; Prognosis; Zidovudine | 1988 |